683 Capital Management’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.8M | Sell |
4,350,000
-285,000
| -6% | -$772K | 0.77% | 23 |
|
|
2025
Q1 | $10.4M | Buy |
4,635,000
+85,000
| +2% | +$191K | 0.72% | 31 |
|
|
2024
Q4 | $15.9M | Sell |
4,550,000
-299,800
| -6% | -$1.05M | 0.99% | 16 |
|
|
2024
Q3 | $19.9M | Sell |
4,849,800
-150,200
| -3% | -$617K | 1.52% | 13 |
|
|
2024
Q2 | $18M | Sell |
5,000,000
-750,000
| -13% | -$2.7M | 1.36% | 16 |
|
|
2024
Q1 | $19M | Sell |
5,750,000
-450,000
| -7% | -$1.49M | 1.39% | 16 |
|
|
2023
Q4 | $14.3M | Buy |
6,200,000
+200,000
| +3% | +$462K | 1.17% | 26 |
|
|
2023
Q3 | $7.74M | Buy |
6,000,000
+600,000
| +11% | +$774K | 0.6% | 44 |
|
|
2023
Q2 | $7.13M | Buy |
5,400,000
+3,400,000
| +170% | +$4.49M | 0.51% | 43 |
|
|
2023
Q1 | $1.41M | Buy |
2,000,000
+1,875,000
| +1,500% | +$1.33M | 0.11% | 106 |
|
|
2022
Q4 | $93.8K | Buy |
+125,000
| New | +$93.8K | 0.01% | 227 |
|